Education
About Us
Working with TipRanks
Follow Us
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 38.42M | ¥ 39.26M | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 |
| Gross Profit | ¥ -672.94M | ¥ 24.24M | ¥ -475.64M | ¥ -66.27M | ¥ 0.00 |
| Operating Income | ¥ -951.21M | ¥ -144.40M | ¥ -2.45B | ¥ -6.01B | ¥ -909.92M |
| EBITDA | ¥ -916.54M | ¥ -45.07M | ¥ -2.39B | ¥ -2.23B | ¥ -335.04M |
| Net Income | ¥ -903.43M | ¥ -138.54M | ¥ -2.45B | ¥ -6.02B | ¥ -915.87M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 427.53M | ¥ 752.97M | ¥ 1.64B | ¥ 2.87B | ¥ 806.51M |
| Total Assets | ¥ 812.74M | ¥ 2.10B | ¥ 4.69B | ¥ 5.35B | ¥ 1.19B |
| Total Debt | ¥ 89.64M | ¥ 334.45M | ¥ 354.37M | ¥ 67.92M | ¥ 22.32M |
| Net Debt | ¥ -311.60M | ¥ -401.41M | ¥ -1.25B | ¥ -2.70B | ¥ -493.87M |
| Total Liabilities | ¥ 2.45B | ¥ 2.83B | ¥ 5.36B | ¥ 4.13B | ¥ 2.17B |
| Stockholders' Equity | ¥ -1.64B | ¥ -732.83M | ¥ -668.14M | ¥ 1.22B | ¥ -982.74M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -290.11M | ¥ -737.05M | ¥ -1.80B | ¥ -998.07M | ¥ 363.13M |
| Operating Cash Flow | ¥ -288.49M | ¥ -727.88M | ¥ -1.69B | ¥ -917.75M | ¥ 476.93M |
| Investing Cash Flow | ¥ 3.17M | ¥ -6.16M | ¥ -37.51M | ¥ 112.12M | ¥ -394.12M |
| Financing Cash Flow | ¥ -51.50M | ¥ -142.41M | ¥ 483.14M | ¥ 3.06B | ¥ 316.85M |
Clover Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.